XPH
State Street SPDR S&P Pharmaceuticals ETF
1W: +1.4%
1M: -7.3%
3M: -5.8%
YTD: -2.6%
1Y: +22.0%
3Y: +35.8%
5Y: +8.3%
$53.25
-0.53 (-0.99%)
After Hours: $52.77 (-0.48, -0.91%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$217M
Holdings58
Top 10 Wt24.8%
Beta0.89
% Profitable47%
Coverage97%
Portfolio Valuation
P/E24.9
P/B1.6
P/S5.4
EV/EBITDA17.4
P/FCF28.5
PEG1.69
Profitability & Returns
Gross Margin77.8%
Net Margin19.6%
ROE9.3%
ROA4.9%
ROIC7.2%
Div Yield0.76%
Leverage & Liquidity
Debt/Equity0.26
Debt/Assets0.15
Net Debt/EBITDA-0.3x
Interest Cov10.4x
Current Ratio1.70
Quick Ratio1.44
Growth (YoY)
Revenue+32.2%
Net Income+26.2%
EPS+32.5%
FCF+7.7%
EBITDA+31.4%
Rev CAGR 3Y+44.6%
Quality Scores
Piotroski F4.9
Altman Z9.00
IS Quality56.1
IS Overall47.6
IS Value43.3
Median P/E-4.5
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 57 | 99.8% | 24.6 |
| Other | 1 | 0.1% | — |
Smart Money Overlap
3 holdings with signals
Showing 50 of 58 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | DEFINIUM THERAPEUTICS INC | DFTX | 3.04% | $9.2M | 497,990 | — | $1.8B | Healthcare |
| 2 | NEKTAR THERAPEUTICS | NKTR | 2.62% | $7.9M | 106,774 | -8.7 | $1.5B | Healthcare |
| 3 | EDGEWISE THERAPEUTICS INC | EWTX | 2.55% | $7.7M | 259,694 | -19.4 | $3.4B | Healthcare |
| 4 | PHIBRO ANIMAL HEALTH CORP A | PAHC | 2.46% | $7.4M | 143,413 | 24.6 | $2.3B | Healthcare |
| 5 | ROYALTY PHARMA PLC CL A | RPRX | 2.40% | $7.3M | 161,137 | 26.4 | $20.1B | Healthcare |
| 6 | ELANCO ANIMAL HEALTH INC | ELAN | 2.38% | $7.2M | 289,442 | -53.2 | $12.7B | Healthcare |
| 7 | MERCK + CO. INC. | MRK | 2.36% | $7.1M | 63,154 | 16.2 | $295.1B | Healthcare |
| 8 | VIATRIS INC | VTRS | 2.35% | $7.1M | 531,476 | -4.4 | $15.5B | Healthcare |
| 9 | JOHNSON + JOHNSON | JNJ | 2.32% | $7.0M | 29,850 | 21.7 | $578.2B | Healthcare |
| 10 | LIGAND PHARMACEUTICALS | LGND | 2.31% | $7.0M | 33,501 | 32.5 | $4.1B | Healthcare |
| 11 | LIQUIDIA CORP | LQDA | 2.31% | $7.0M | 188,652 | -46.5 | $3.2B | Healthcare |
| 12 | BRISTOL MYERS SQUIBB CO | BMY | 2.29% | $6.9M | 120,389 | 17.2 | $120.0B | Healthcare |
| 13 | ENLIVEN THERAPEUTICS INC | ELVN | 2.29% | $6.9M | 232,531 | -21.6 | $2.1B | Healthcare |
| 14 | MAZE THERAPEUTICS INC | MAZE | 2.24% | $6.8M | 138,283 | -10.5 | $1.5B | Healthcare |
| 15 | JAZZ PHARMACEUTICALS PLC | JAZZ | 2.22% | $6.7M | 37,371 | -32.5 | $11.6B | Healthcare |
| 16 | TERNS PHARMACEUTICALS INC | TERN | 2.22% | $6.7M | 138,201 | -51.4 | $4.8B | Healthcare |
| 17 | INNOVIVA INC | INVA | 2.16% | $6.5M | 298,987 | 6.3 | $1.5B | Healthcare |
| 18 | AXSOME THERAPEUTICS INC | AXSM | 2.15% | $6.5M | 41,304 | -45.5 | $8.3B | Healthcare |
| 19 | PFIZER INC | PFE | 2.15% | $6.5M | 239,141 | 20.2 | $155.3B | Healthcare |
| 20 | AMYLYX PHARMACEUTICALS INC | AMLX | 2.14% | $6.5M | 465,995 | -8.9 | $1.1B | Healthcare |
| 21 | SUPERNUS PHARMACEUTICALS INC | SUPN | 2.13% | $6.5M | 133,560 | -75.4 | $2.9B | Healthcare |
| 22 | AMNEAL PHARMACEUTICALS INC | AMRX | 2.04% | $6.2M | 504,924 | 52.6 | $3.9B | Healthcare |
| 23 | MBX BIOSCIENCES INC | MBX | 1.99% | $6.0M | 213,919 | -11.8 | $973M | Healthcare |
| 24 | ZOETIS INC | ZTS | 1.98% | $6.0M | 52,216 | 19.2 | $51.4B | Healthcare |
| 25 | PRESTIGE CONSUMER HEALTHCARE | PBH | 1.97% | $6.0M | 100,471 | 15.5 | $2.9B | Healthcare |
| 26 | ELI LILLY + CO | LLY | 1.86% | $5.6M | 6,204 | 39.1 | $865.9B | Healthcare |
| 27 | RAPPORT THERAPEUTICS INC | RAPP | 1.85% | $5.6M | 205,680 | -12.3 | $1.1B | Healthcare |
| 28 | ANI PHARMACEUTICALS INC | ANIP | 1.84% | $5.6M | 75,157 | 19.8 | $1.7B | Healthcare |
| 29 | PACIRA BIOSCIENCES INC | PCRX | 1.81% | $5.5M | 244,842 | 142.3 | $1.0B | Healthcare |
| 30 | ORGANON + CO | OGN | 1.76% | $5.3M | 858,653 | 8.4 | $1.6B | Healthcare |
| 31 | INDIVIOR PHARMACEUTICALS INC | INDV | 1.74% | $5.3M | 173,910 | 17.9 | $3.8B | Healthcare |
| 32 | ARVINAS INC | ARVN | 1.70% | $5.2M | 465,429 | -8.7 | $701M | Healthcare |
| 33 | EYEPOINT INC | EYPT | 1.66% | $5.0M | 368,728 | -4.7 | $1.1B | Healthcare |
| 34 | TARSUS PHARMACEUTICALS INC | TARS | 1.66% | $5.0M | 75,813 | -43.7 | $2.8B | Healthcare |
| 35 | XERIS BIOPHARMA HOLDINGS INC | XERS | 1.62% | $4.9M | 888,346 | 1676.1 | $914M | Healthcare |
| 36 | TREVI THERAPEUTICS INC | TRVI | 1.52% | $4.6M | 435,080 | -41.1 | $1.5B | Healthcare |
| 37 | CRINETICS PHARMACEUTICALS IN | CRNX | 1.50% | $4.6M | 128,280 | -7.4 | $3.8B | Healthcare |
| 38 | COLLEGIUM PHARMACEUTICAL INC | COLL | 1.50% | $4.5M | 126,180 | 16.8 | $1.1B | Healthcare |
| 39 | PERRIGO CO PLC | PRGO | 1.44% | $4.4M | 456,000 | -0.9 | $1.3B | Healthcare |
| 40 | HARMONY BIOSCIENCES HOLDINGS | HRMY | 1.43% | $4.3M | 156,993 | 10.0 | $1.6B | Healthcare |
| 41 | HARROW INC | HROW | 1.38% | $4.2M | 122,811 | -255.9 | $1.4B | Healthcare |
| 42 | ESPERION THERAPEUTICS INC | ESPR | 1.37% | $4.1M | 1,609,690 | -29.8 | $574M | Healthcare |
| 43 | PHATHOM PHARMACEUTICALS INC | PHAT | 1.33% | $4.0M | 365,323 | -3.6 | $825M | Healthcare |
| 44 | AMPHASTAR PHARMACEUTICALS IN | AMPH | 1.30% | $3.9M | 202,562 | 9.2 | $899M | Healthcare |
| 45 | ZEVRA THERAPEUTICS INC | ZVRA | 1.29% | $3.9M | 419,799 | 6.3 | $536M | Healthcare |
| 46 | WAVE LIFE SCIENCES LTD | WVE | 1.21% | $3.7M | 304,752 | -5.5 | $2.3B | Healthcare |
| 47 | OMEROS CORP | OMER | 1.17% | $3.6M | 322,386 | -5.6 | $740M | Healthcare |
| 48 | NUVATION BIO INC | NUVB | 1.10% | $3.3M | 786,368 | -7.4 | $1.5B | Healthcare |
| 49 | OCULAR THERAPEUTIX INC | OCUL | 1.08% | $3.3M | 400,073 | -6.8 | $1.8B | Healthcare |
| 50 | CORMEDIX INC | CRMD | 0.97% | $2.9M | 468,416 | 3.2 | $523M | Healthcare |